artenimol has been researched along with transferrin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, H; Singh, NP | 2 |
| Kim, MS; Kim, SJ; Lee, CH; Lee, JW; Lee, SH; Park, MJ; Shin, SH; Yoo, H | 1 |
| Wang, Z; Zhou, HJ | 1 |
| Lacoste, E; Lai, H; Nakase, I; Sasaki, T; Singh, NP | 1 |
| Chaijaroenkul, W; Mahavorasirikul, W; Na-Bangchang, K; Viyanant, V | 1 |
| Ba, Q; Chen, T; Chu, R; Duan, J; Hao, M; Li, J; Wang, H; Yang, X; Yin, J; Zhou, N | 1 |
| Lai, HC; Park, J; Sasaki, T; Singh, M; Singh, NP | 1 |
| Lai, HC; Park, J; Sasaki, T; Singh, NP | 1 |
| Chen, Q; Liu, L; Wei, Y; Xing, D; Zhai, S | 1 |
| Huo, L; Wang, Q; Wu, S; Zhao, C; Zhao, H; Zhao, X | 1 |
| Dai, L; Lei, J; Li, C; Liu, J; Liu, K; Wang, L | 1 |
| Gong, S; Hu, Y; Lu, M; Luo, Y; Ma, XN; Tian, J; Wu, Y; Xu, Z; Yu, BY; Yu, XA; Zhang, Y | 1 |
13 other study(ies) available for artenimol and transferrin
| Article | Year |
|---|---|
Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin.
Topics: Artemisinins; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Humans; Lymphocytes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Time Factors; Transferrin; Tumor Cells, Cultured | 1995 |
Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.
Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Breast; Breast Neoplasms; Cell Survival; Drug Combinations; Female; Humans; Sesquiterpenes; Transferrin; Tumor Cells, Cultured; X-Rays | 2001 |
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Antimalarials; Artemisinins; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Gamma Rays; Glioma; Glutathione Transferase; Humans; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sesquiterpenes; Transferrin; Tumor Stem Cell Assay | 2006 |
[Dihydroartemisinin down-regulates the expression of transferrin receptor in myeloid leukemia cells].
Topics: Antineoplastic Agents, Phytogenic; Artemisinins; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; HL-60 Cells; Humans; K562 Cells; Receptors, Transferrin; RNA, Messenger; Transferrin | 2008 |
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Topics: Adenocarcinoma; Animals; Artemisinins; Female; Injections, Intravenous; Mammary Neoplasms, Experimental; Random Allocation; Rats; Rats, Inbred F344; Transferrin | 2009 |
Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines.
Topics: Antigens, CD; Antineoplastic Agents; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholangiocarcinoma; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression; Humans; Liver Neoplasms; Receptors, Transferrin; Transferrin | 2011 |
Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1.
Topics: Antigens, CD; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Membrane; Down-Regulation; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Homeostasis; Humans; Intracellular Space; Iron; Membrane Microdomains; Neoplasms; Receptors, Transferrin; Transferrin | 2012 |
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia; Transferrin; Tumor Cells, Cultured | 2014 |
DNA damage in dihydroartemisinin-resistant Molt-4 cells.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Comet Assay; DNA Damage; Drug Resistance, Neoplasm; Humans; Transferrin | 2015 |
Dihydroartemisinin and transferrin dual-dressed nano-graphene oxide for a pH-triggered chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diffusion; Female; Graphite; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanocapsules; Neoplasms, Experimental; Oxides; Particle Size; Transferrin; Treatment Outcome | 2015 |
Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Survival; Gene Expression; Humans; Jurkat Cells; Lymphoma, T-Cell; Reactive Oxygen Species; Receptors, Transferrin; RNA, Messenger; Telomerase; Transferrin; Vascular Endothelial Growth Factor A | 2015 |
Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
Topics: A549 Cells; Animals; Antineoplastic Agents; Artemisinins; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Hydrolysis; Inhibitory Concentration 50; Ligands; Mice; Nanoparticles; Neoplasm Transplantation; Particle Size; Polyethylene Glycols; Receptors, Transferrin; Solubility; Tissue Distribution; Transferrin; Xenograft Model Antitumor Assays | 2016 |
A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
Topics: Animals; Artemisinins; Buthionine Sulfoximine; Drug Carriers; Female; Glutathione; Hep G2 Cells; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Oxidative Stress; Precision Medicine; Reactive Oxygen Species; Transferrin | 2020 |